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Background: Response evaluation criteria in solid tumours (RECIST) has significant limitations in terms of
variability and reproducibility, which may not be independent. The aim of the study was to evaluate the
precision of manual bi-dimensional segmentation of lung, liver metastases, and to quantify the uncertainty in
tumour response assessment.
Methods: A total of 520 segmentations of metastases from six livers and seven lungs were independently performed
by ten physicians and ten scientists on CT images, reflecting the variability encountered in clinical practice. Operators
manually contoured the tumours, firstly independently according to the RECIST and secondly on a preselected slice.
Diameters and areas were extracted from the segmentations. Mean standard deviations were used to build regression
models and 95% confidence intervals (95% CI) were calculated for each tumour size and for limits of progressive
disease (PD) and partial response (PR) derived from RECIST 1.1.
Results: Thirteen aberrant segmentations (2.5%) were observed without significant differences between the physicians
and scientists; only the mean area of liver tumours (p = 0.034) and mean diameter of lung tumours (p = 0.021) differed
significantly. No difference was observed between the methods. Inter-observer agreement was excellent (intra-class
correlation >0.90) for all variables. In liver, overlaps of the 95% CI with the 95% CI of limits of PD or PR were observed
for diameters above 22.7 and 37.9 mm, respectively. An overlap of 95% CIs was systematically observed for area. No
overlaps were observed in lung.
Conclusions: Although the experience of readers might not affect the precision of segmentation in lung and liver, the
results of manual segmentation performed for tumour response assessment remain uncertain for large liver metastases.
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Tumour progression and response to treatment are cur-
rently evaluated according to response criteria based on
morphologic imaging such as those firstly proposed by the
World Health Organization (WHO) or by the more widely
used Response evaluation criteria in solid tumours
(RECIST) [1, 2]. Developed to simplify the assessment of
tumour response, these two evaluation systems are baseddistributed under the terms of the Creative Commons Attribution 4.0
/licenses/by/4.0/), which permits unrestricted use, distribution, and
ppropriate credit to the original author(s) and the source, provide a link to
nges were made.
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axes, corresponding to an assessment of anatomical
tumour burden and changes in the measure over time,
with the ultimate goal of categorizing adequate tumour
response [3].
RECIST has been demonstrated to be useful in clinical
trials where objective response was the primary study end-
point as well as in trials where assessment of stable disease,
tumour progression or time-to-progression analyses were
undertaken [2, 4]. In RECIST, measurable disease is de-
fined by the presence of at least one measurable lesion [5].
Target tumours should be selected on the basis of their size
and be representative of all involved organs, but in addition
should be those that lend themselves to reproducible
repeated measurements. Thus, it is possible to define a par-
tial response (PR), corresponding to at least a 30% decrease
in the sum of diameters of target tumours, taking as refer-
ence the baseline sum diameters [2]. Progressive disease
(PD) is an increase of at least 20% in the sum of diameters
of target tumours, taking as reference the smallest sum.
However, RECIST has significant limitations in terms of
variability and reproducibility, which may not be independ-
ent [6–9]. In practice, the maximal size mensuration or
segmentation (in two or three dimensions) are performed
manually and concerns remain about the accuracy of such
segmentation as a result of interobserver and intraobserver
variability [10]. A recent meta-analysis has shown that in-
terobserver relative measurement difference in measuring
single tumour burden and calculating the interval change
may exceed the 20% cut-off for progression [11]. However,
variability decreased when tumour burden was measured
by a single observer or assessed by the sum of multiple
tumours [11].
The aim of our study was: firstly to evaluate the precision
of manual two-dimensional (2D) segmentations depending
on organ, reader experience, and segmentation method;
and secondly to quantify the uncertainty in tumour re-
sponse assessment (PR, PD or stable disease) depending on
the segmentation precision.Methods
This retrospective study was approved by the institutional
research ethics board. The requirement for patient in-
formed consent was waived. The authors had full control
of the data and the information submitted for publication.Study cohort
Data were extracted from our large departmental elec-
tronic database of de-identified computed tomography
(CT) images involving two university hospitals. Contrast-
enhanced CT scans were obtained in the period from
2010 to 2015 using 0.7–1.2 mm pixel spacing, 1.25–5 mm
slice thickness, 120 kVp, and different convolution kernelsor constructors (General Electrics, Milwaukee, USA;
Siemens, Erlangen, Germany; Phillips, Best, Netherlands).
Two investigators selected the tumours to reflect the
variability in location, size, and shape of liver and lung me-
tastases, CT acquisition, reconstruction, and body mass,
which all affect the contrast-to-noise ratio and therefore
the ease of determination of tumour borders. However, tu-
mours were selected irrespective of primary tumour type
or other patient demographics. The number of segmenta-
tions was calculated to evaluate the precision of manual
segmentation depending on reader experience, on different
organs, and using two different segmentation methods.
The number of tumours and readers involved in this study
was adjusted to ensure sufficient statistical power and a
total number of image segmentations greater than 500.
Image analysis
Datasets were imported into OsiriX, version 5.9 (OsiriX,
Geneva, Switzerland), an open source DICOM image ana-
lysis suite and picture archiving and communication system
workstation designed for the Apple Macintosh platform.
Twenty readers independently analysed CT data from 13
identified non-treated index liver and lung metastases (six
livers and seven lungs) using two different methods. Ten
readers were radiologists with experience ranging from 1 to
25 years (group 1) and ten readers were scientists with basic
knowledge on image segmentation (group 2).
Method 1 consisted of selecting the slice for a given
tumour where a mensuration of diameter could be per-
formed according to RECIST or WHO methods and
subsequent manual contouring of the tumour on this
slice in 2D. While not representative of typical radiologic
practice, maximal diameter was automatically extracted
from this contour in order to simplify the experimental
design. Moreover, for patients with multiple tumours, an
approximate tumour location was given by a range of
slices where the tumour could be located.
Method 2 consisted of performing the same manual
contouring, but the readers were aware of the slice num-
ber and tumour location. Method 2 was performed after
method 1. Both groups performed both methods. Re-
gions of interest (ROIs) were exported to the Federative
Platform for Research in Computer Science and Math-
ematics (PlaFRIM). The PlaFRIM experimental test bed
was used to perform the statistical analysis.
Statistical analysis
Only adequate segmentations were selected for subsequent
evaluation. Segmentations were considered as inadequate if
performed at least two slices away from the slice most
often selected by all the readers or not only on the pre-
identified nodule; these segmentations were excluded from
the analysis. A χ2 test was used for independence. Mean,
minimum/maximum values, and standard deviation (SD)
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to organ, group of readers, and methods. To minimize the
effect of tumour size factor, measurement variability was
expressed as a percentage of the mean diameter/area meas-
urement. Thus, mean SD was divided by the mean diameter
or area (mean SD/diameter or area). Mean values were
compared using Wilcoxon signed rank test.
To determine interobserver agreement, the between-
subject SD and within-subject SD of each variable were
compared. Intraclass correlation coefficients (ICCs) were
calculated based on repeated measures ANOVA [12, 13].
ICC results were interpreted according to the following
criteria: poor (ICC <0.50), moderate (0.50 < ICC < 0.75),
good (0.75 < ICC < 0.90), and excellent (ICC > 0.90).
The SD was considered to reflect the variation of segmen-
tation. The mean SD of each diameter or area was plotted
according to the respective diameter or area of the tumours
in lung and liver. A regression analysis was performed to de-
rive the 95% confidence interval (95% CI) of diameter and
area in each organ and for each size. This 95% CI reflects
the uncertainty of segmentation whatever the diameter or
the area of the tumour. The same 95% CI was also applied
for the limits of RECIST 1.1 criteria of PD (+20%) and PR
(−30%) either on diameter or on area. The purpose was to
detect overlap between the 95% CI of diameter or area and
limits of PD or PR. The RECIST was extended to area (A)
by adapting the limits of PD and PR using the formula A
= π r2. A cut-off value of diameter or area was determined if
identified at the intersection of the overlap. A p value greater
than 0.050 was considered to indicate a significant differ-
ence. All analyses were conducted using Stata 12.0 (Stata-
Corp, College Station, Texas, United States).
Results
A total of 507 segmentations were selected for further evalu-
ation. A total of 13 contours (2.5%, 13/520) were removed
due to consistent errors of segmentation, all observed afterFig. 1 After preselection of the tumours, manual segmentations were perfo
then on a preselected slice. Aberrant segmentations were excluded from th
line corresponds to a segmentation performed by a physician, the inner lin
excluded. b Example segmentations performed in lung. The purple line cor
one performed by a scientist. The outer segmentation (arrow) was excludemethod 1 (260 segmentations) (Fig. 1). Among these 13 ab-
errant segmentations, four were performed by radiologists
(three in liver, one in lung) and nine by scientists (three liver,
six lung). No significant differences were observed be-
tween the two groups (p = 0.261).
Interobserver agreement
Between the groups, the mean values did not differ signifi-
cantly whatever the organ or the method used except only
for the mean area of liver tumours (p = 0.034) and mean
diameter of lung tumours (p = 0.021) (Additional file 1).
Comparing measurements obtained according to methods
1 and 2, no significant differences were observed between
the groups or after combining the groups.
Interobserver agreements were excellent (ICC > 0.90)
for all variables; after combining all readings, ICC were
99.1 and 99.4% for diameter and area, respectively.
Impact on the evaluation of area and maximum diameter
After combination of the values of both groups and both
methods (Table 1), regression models were obtained
(Fig. 2). After implementation of these regression models
in both organs, 95% CIs were successfully calculated for
each tumour size and for limits of PD and PR. No overlap
of 95% CIs was observed in the lung (Figs. 3a, b and 4a, b).
In the liver, the 95% CIs of tumour diameter and area over-
lapped with the 95% CIs of limits of PD and PR (Figs. 3
and 4). The cut-off value was x1 = 22.7 mm at the intersec-
tion of the 95% CIs of tumour diameter and limits of PD
(Fig. 3c). Similarly, the cut-off was x2 = 37.9 mm at the
intersection of the 95% CIs of tumour diameter and limits
of PR (Fig. 3d). An overlap of 95% CIs was systematically
observed for area in liver.
Discussion
Among the 520 segmentations performed, only 2.5% of
segmented ROIs were removed due to consistent errorsrmed independently by the operators according to the RECIST and
e analysis. a. Example segmentations performed in liver. The purple
e one performed by a scientist. The outer segmentation (arrow) was
responds to a segmentation performed by a physician, the inner line
d
Table 1 Overall results of area (cm2) or maximum diameter (mm) evaluation for lung and liver lesions
Area (cm2) Diameter (mm)
Mean value SD SD/mean Min Max Mean value SD SD/mean Min Max
Liver 1 1.46 0.14 0.1 1.03 1.61 17.66 0.94 0.05 15.23 19.02
Liver 2 11.66 2.96 0.25 8.46 18.62 46.02 4.06 0.09 40.28 57.06
Liver 3 30.21 6.40 0.21 15.47 45.51 76.72 10.14 0.13 51.83 105.49
Liver 4 4.88 0.37 0.08 3.92 5.78 27.22 1.03 0.04 24.68 29.21
Liver 5 7.58 0.75 0.1 6.39 9.20 35.71 2.61 0.07 31.79 41.74
Liver 6 22.32 4.11 0.18 14.55 27.01 61.77 7.67 0.12 50.97 77.78
Lung 1 1.32 0.19 0.14 0.89 1.60 14.30 0.07 0 12.23 15.83
Lung 2 0.31 0.04 0.13 0.21 0.36 7.43 0.37 0.05 6.51 8.14
Lung 3 0.55 0.10 0.18 0.34 0.77 10.76 1.04 0.1 8.88 12.61
Lung 4 4.87 0.43 0.09 4.06 5.75 29.86 2.43 0.08 24.95 34.52
Lung 5 15.19 0.39 0.03 14.32 15.93 48.78 0.76 0.02 47.33 50.27
Lung 6 2.60 0.26 0.1 1.99 2.96 22.67 2.22 0.1 17.54 27.16
Lung 7 1.42 0.15 0.11 1.18 1.69 16.28 1.03 0.06 14.81 18.33
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ologists and scientists was observed. Moreover, while
considerable interobserver and intraobserver variability
has been reported thus far for radiological tumour re-
sponse evaluation according to RECIST and WHO criteriaFig. 2 Regression models of the standard deviation according to maximum d
the mean maximum diameter of the seven segmentations performed in the lu
the maximum diameter but remained below 2.5 mm whatever the size of the
b Mean standard deviation according to mean area for each tumour in the lun
each segmented tumour in the liver (n = 6). The relative uncertainty increased
area for each tumour in the liver[11, 14], inter-observer agreements were excellent (ICC
>0.90) for diameter and area assessment in both organs.
These observations may be related to the method used
in this study. While not representative of typical radio-
logic practice, the maximum diameter was calculatediameter (in mm) or area (in cm2). a Mean standard deviation according to
ng. A relative dispersion of the mean standard deviation was observed for
segmented tumour. The relative uncertainty decreased with the size.
g. c Mean standard deviation according to mean maximum diameter for
with the size of the lesion. d Mean standard deviation according to mean
Fig. 3 The 95% confidence intervals (95% CIs) obtained for the limits of RECIST 1.1 criteria of stable disease, progressive disease (PD), and partial
response (PR) using diameter. In the lung, it appeared that standard deviation decreased as diameter or area of the segmented tumour increased.
The opposite was observed in the liver. a The 95% CI of the stable disease (y = x) in the lung did not cross the calculated 95% CI of the lower
bound of PD (y = 1.2x). b The 95% CI of the stable disease in the lung did not cross the calculated 95% CI of the upper bound of PR (y = 0.7x). c
The 95% CI of the stable disease in liver shows an overlap (blue zone) with 95% CI of the lower bound of PD. The cut-off value was x1 = 22.7 mm
(dashed line). d The 95% CI of the stable disease in the liver did cross the calculated 95% CI of the upper bound of PR (blue zone). The cut-off
value was x2 = 37.9 mm (dashed line)
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analysis was performed to simplify the experimental de-
sign and limit the bias. Moreover, for patients with mul-
tiple tumours, an approximate tumour location was
given by a range of slices where the tumour could be
located. While this method appeared effective and con-
firmed the call for computer-aided detection software
for tumour response assessment [15], it remains uncer-
tain how the results are generalizable in clinical practice.
Further evaluations are now mandatory.
Based on the regression models of SD performed in
this study, the level of uncertainty increased with
tumour size in the liver while it decreased in the lung.
In liver, therefore, 2D segmentation findings have to becarefully interpreted due to these increasing 95% CIs. A
potential impact on tumour response assessment may be
observed either for area or for diameter. For area, 95%
CIs systematically overlapped. This finding suggests the
limited interest of area calculation for therapeutic as-
sessment. For diameter, cut-off values were identified at
the intersection of these overlaps, above which it may
be difficult to assess confidently therapeutic response.
For tumours above these thresholds the impression of
progression or partial response may only be related to
the uncertainty of the measures. These size limits have
to be taken into account in further evaluations of
RECIST [2, 16]. This justifies the development of alter-
natives for liver, such as the recently proposed modified
Fig. 4 The 95% confidence intervals (95% CIs) obtained for the limits of criteria of stable disease, progressive disease (PD), and partial response
(PR) using area. In liver, the 95% CI of area systematically overlapped across all tumour sizes for both partial response and progressive disease. a
The 95% CI of the stable disease (y = x) in the lung did not cross the calculated 95% CI of the lower bound of PD (y = 1.44 x). b The 95% CI of
the stable disease in the lung did not cross the calculated 95% CI of the upper bound of PR (y = 0.47 x). c The 95% CI of the stable disease in
liver systematically shows an overlap (blue zone) with the 95% CI of the lower bound of PD. d The 95% CI of the stable disease in the liver always
crossed the calculated 95% CI of the upper bound of PR (blue zone)
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imaging in the current evaluation of liver metastases after
treatment [17, 18]. In the lung, greater uncertainty was
observed for small tumours. This finding is consistent
with the introduction of a minimum lesion size in RECIST
of 10 mm in the lung, which improved reproducibility
between WHO and RECIST [19].
This study showed that there were no significant dif-
ferences in terms of uncertainty between segmentations
made by a group of radiologists aware of RECIST and
those of a group of scientists with only basic knowledge
of RECIST. The SD remained similar for both groups.
Moreover, no significant differences were observed be-
tween the groups, or after combining the groups, when
comparing mensuration obtained on an imposed slice orafter the selection of the slice. Therefore, 2D segmenta-
tion, even manual, seems not to be affected by a slight
variation in slice selection. These findings justify the
RECIST 1.1 recommendations to perform mensuration
using the same plane of evaluation with the maximum
diameter of each target lesion always being measured at
subsequent follow-up time points, even if this results in
measuring the lesion at a different slice level or in a dif-
ferent orientation or vector compared with the baseline
study [2, 16].
This study has some limitations. The series is retro-
spective and may have selection bias. The number of tu-
mours evaluated is limited and tumours were chosen by
two independent investigators, which may have caused
selection bias. No comparison of the findings was
Cornelis et al. European Radiology Experimental  (2017) 1:16 Page 7 of 7performed with the results of a single observer or after
summing multiple tumours [11]. The segmentation was
performed manually but the diameters were extracted
automatically. Further studies may compare the results of
manual versus automatic segmentations [20, 21]. Volu-
metric assessment of the entire tumour has not been per-
formed, as recently proposed [22]. However, volumetric
assessment and RECIST have been shown not to be inter-
changeable, neither technique demonstrating clinical su-
periority [23, 24].
To summarize, the results of our study highlight the
concerns remaining for manual segmentation, although
accuracy of manual 2D segmentation does not appear to
be limited by the experience of operator. For liver but not
for lung metastases, segmentation in 2D for response as-
sessment remains uncertain for large tumours. We estab-
lished thresholds above which the impression of tumour
progression or response may be related only to the uncer-
tainty of 2D segmentation. While a prospective validation
of these findings on a larger scale is now needed before
drawing definitive conclusions regarding their true impact
from a clinical perspective, these results could be easily in-
corporated in daily clinical practice. Moreover, it may jus-
tify the development of alternative quantitative assessment
of tumour response using multiparametric or functional
imaging tools.
Additional file
Additional file 1: Table S1. Summary of the results for each group in
the liver and the lung according to the two methods. (DOC 75 kb)
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